Cargando…

Corrigendum to: Low dose peripheral systemic thrombolysis for treatment of intermediate–high risk acute pulmonary embolism: a case series

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743960/ https://www.ncbi.nlm.nih.gov/pubmed/36518329 http://dx.doi.org/10.1093/ehjcr/ytac467

Ejemplares similares

Low dose peripheral systemic thrombolysis for treatment of intermediate–high risk acute pulmonary embolism: a case series
por: Charif, Fida, et al.
Publicado: (2022)

Reduced-Dose Intravenous Thrombolysis for Acute Intermediate–High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial
por: Sanchez, Olivier, et al.
Publicado: (2021)

Pulmonary artery catheter-directed thrombolysis for intermediate high risk acute pulmonary embolism
por: Singh, Abhijeet, et al.
Publicado: (2017)

Low-dose thrombolysis for submassive pulmonary embolism
por: Yilmaz, Emine Serap, et al.
Publicado: (2021)

The Efficacy and Safety of Intermittent Low-Dose Urokinase Thrombolysis for the Treatment of Senile Acute Intermediate-High-Risk Pulmonary Embolism: A Pilot Trial
por: Zhao, Tianming, et al.
Publicado: (2018)

Comparison of therapeutic effect of catheter direct thrombolysis and peripheral venous thrombolysis on acute pulmonary embolism
por: Guan, Qinglong, et al.
Publicado: (2023)

A systematic review for the role of systemic thrombolysis in intermediate-risk (submassive) pulmonary embolism
por: Seif, Mohamed Ahmed
Publicado: (2020)

Thrombolysis with reteplase in acute pulmonary embolism
por: Nishanth, K.R., et al.
Publicado: (2019)

Catheter-directed thrombolysis compared with systemic thrombolysis and anticoagulation in patients with intermediate- or high-risk pulmonary embolism: systematic review and network meta-analysis
por: Planer, David, et al.
Publicado: (2023)

Corrigendum: Interventional Therapy for Bilateral Acute Renal Artery Embolism Caused by Paroxysmal Atrial Fibrillation
Publicado: (2016)

Urokinase versus Alteplase in Patients with Intermediate–High-Risk Pulmonary Embolism Treated with Ultrasound-Accelerated Endovascular Thrombolysis
por: Al-Terki, Hani, et al.
Publicado: (2023)

The net benefit of thrombolysis in the management of intermediate risk pulmonary embolism: Systematic review and meta‐analysis
por: Alcedo, Pedro E., et al.
Publicado: (2020)

Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis?
por: Bhamani, Amyn, et al.
Publicado: (2019)

Thrombolysis in Acute Pulmonary Embolism: Are we overdoing it?
por: Showkathali, Refai, et al.
Publicado: (2021)

Corrigendum to “Benefits of Low-Dose CT Scan of Head for Patients with Intracranial Hemorrhage”
Publicado: (2021)

Effects of Ambient Temperature on Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Results from a Time-Series Analysis of 143318 Hospitalizations [Corrigendum]
Publicado: (2021)

Intermediate-High Risk Pulmonary Embolism
por: Mirambeaux, Rosa, et al.
Publicado: (2019)

Corrigendum to “Benign course after acute high dose levothyroxine intoxication in a 3-year-old boy”
por: Hartman, Stan, et al.
Publicado: (2020)

Corrigendum to “Improvement of Memory by Means of Ultra-Low Doses of Antibodies to S-100B Antigen”
por: Evidence-Based Complementary and Alternative Medicine,
Publicado: (2020)

Ultrasound-assisted catheter-directed thrombolysis compared with anticoagulation alone for treatment of intermediate-risk pulmonary embolism
por: Schissler, Andrew J., et al.
Publicado: (2018)

Systemic thrombolysis with newer thrombolytics vs anticoagulation in acute intermediate risk pulmonary embolism: a systematic review and meta-analysis
por: Mathew, Don, et al.
Publicado: (2023)

Corrigendum to “High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis”
por: Cherin, Patrick, et al.
Publicado: (2015)

Low-dose thrombolytic therapy versus unfractionated heparin in patients with intermediate-high risk pulmonary embolism
por: Surgit, Ozgur, et al.
Publicado: (2023)

Increased radiosensitivity of colorectal tumors with intra-tumoral injection of low dose of gold nanoparticles [Corrigendum]
Publicado: (2019)

Corrigendum to “Total Intravenous Anaesthesia with High-Dose Remifentanil Does Not Aggravate Postoperative Nausea and Vomiting and Pain, Compared with Low-Dose Remifentanil: A Double-Blind and Randomized Trial”
por: Kim, Seong-Hyop, et al.
Publicado: (2019)

Low-dose urokinase thrombolytic therapy for patients with acute intermediate-high-risk pulmonary embolism: A retrospective cohort study
por: Weng, Cuilian, et al.
Publicado: (2021)

The Safety and Efficacy of Ultrasound-Accelerated Catheter-Directed Thrombolysis in Patients with Intermediate–High-Risk Pulmonary Embolism: Bo-NE-Experience
por: Al-Terki, Hani, et al.
Publicado: (2023)

The Main Causes and Mechanisms of Increase in Cardiac Troponin Concentrations Other Than Acute Myocardial Infarction (Part 1): Physical Exertion, Inflammatory Heart Disease, Pulmonary Embolism, Renal Failure, Sepsis [Corrigendum]
Publicado: (2021)

Pulmonary hemodynamic profile in chronic obstructive pulmonary disease [Corrigendum]
Publicado: (2015)

Nasal high-flow in acute hypercapnic exacerbation of COPD [Corrigendum]
Publicado: (2019)

Corrigendum to article “Micro-homology intermediates: RecA’s transient sampling revealed at the single molecule level’’
por: Lee, Andrew J, et al.
Publicado: (2021)

Corrigendum: An Increased Proportion of Apoptosis in CD4(+) T Lymphocytes Isolated from the Peripheral Blood in Patients with Stable Chronic Obstructive Pulmonary Disease
por: Ju, Jinyung
Publicado: (2018)

Corrigendum to “High Dose Dexmedetomidine: Effective as a Sole Agent Sedation for Children Undergoing MRI”
por: Ahmed, Sheikh Sohail, et al.
Publicado: (2015)

Corrigendum to: Pulmonary Hypertension in Heart Failure Patients
por: Rao, Sriram D, et al.
Publicado: (2020)

EKOS(TM) in Octogenarians: The Safety and Efficacy of Ultrasound-Accelerated Catheter-Directed Thrombolysis in Elderly Patients with Intermediate-High-Risk Pulmonary Embolism
por: Al-Terki, Hani, et al.
Publicado: (2023)

Retrospective Analysis of Direct-Acting Oral Anticoagulants (DOACs) Initiation Timing and Outcomes After Thrombolysis in High- and Intermediate-Risk Pulmonary Embolism
por: Wolfe, Adam, et al.
Publicado: (2023)

Corrigendum to “HDR Brachytherapy in the Management of High-Risk Prostate Cancer”
por: Masson, Susan, et al.
Publicado: (2016)

MASSIVE PULMONARY EMBOLISM TREATED WITH THROMBOLYSIS IN COVID-19: A CASE SERIES
por: Alarcon-Calderon, Amarilys, et al.
Publicado: (2020)

Corrigendum to “Acute Amiodarone Pulmonary Toxicity after Drug Holiday: A Case Report and Review of the Literature”
por: Abuzaid, Ahmed, et al.
Publicado: (2015)

Thrombolysis of Postoperative Acute Pulmonary Embolism with a Thrombus in Transit
por: Mardinger, Cynthia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pb3bvof6nlhlog5esaoi64irph